Efficacy of Tocilizumab in Patients with COVID-19

Efficacy of Tocilizumab in Patients with COVID-19

Background and purpose: Tocilizumab (TCZ), a monoclonal antibody against interleukin-6 (IL-6) receptor, is emerged as an alternative treatment for COVID-19 patients with a risk of cytokine storms. This study aimed at investigating the efficacy of TCZ in patients with COVID-19. Materials and methods:...

Full description

Bibliographic Details
Main Authors: Ahmad Alikhani, Zahra Nekoukar, Minoo Moghimi, Maysam Rezapour, Seyyed Javad Boskabadi, Amir Mohammad Shabani, Hamideh Abbaspour Kasgari
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2022-12-01
Series:Journal of Mazandaran University of Medical Sciences
Subjects:
tocilizumab
il6
covid-19
cytokine storm
Online Access:http://jmums.mazums.ac.ir/article-1-18510-en.html

Internet

http://jmums.mazums.ac.ir/article-1-18510-en.html

Similar Items